| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |